HemeOnc
Vulvar Cancer
search
Vulvar Cancer
, Carcinoma of the vulva
Epidemiology
Most common over age 65 years
Also affects <40 years (15% of cases)
Associated with HPV Infection
Types
Type I (Ages: 35 to 65 years)
Poorly differentiated basaloid lesions
Vulvar intraepithelial neoplasia
(VIN)
Pre-malignant lesion
Associated with HPV infection (esp. 16, 18, 31)
Tobacco Abuse
is a predisposing factor
Type II (Ages: 55 to 85 years)
Well-differentiated squamous cell cancer
Vulva
r Non-neoplastic Epithelial Disorders (VNED)
Vulva
r inflammation
Lichen Sclerosis
Squamous cell hyperplasia
Symptoms
Vulvar Pruritus
(most common)
Vulva
r bleeding or discharge
Vulvar Pain
Dysuria
Signs
Raised exophytic vulvar lesion
May be white or erythematous
Most commonly affects labia majora
Staging
Stage 0 (Tis): Carcinoma in situ
Stage I (T1 N0 M0): Confined to vulva/perineum (<2 cm)
Stage II (T2 NO MO): Confined to vulva/perineum (>2 cm)
Stage III (T1-3 N1 M0): Regional
Lymph Node
metastasis
Stage IVA (T1-4 N2 M0): Pelvic metastasis
Stage IVB (T1-4 N0-2 M1): Distant metastasis
Differential Diagnosis
Other vulvar malignancies
Paget Disease
(<1% of vulvar malignancies)
Melanoma
(2% of vulvar malignancies)
Bartholin's Gland Carcinoma (rare)
Basal Cell Carcinoma
of vulva (rare)
Sarcoma
of vulva (rare)
Verrucous Carcinoma (rare)
Management
Surgical excision
Primary lesion removed with 1 cm margin
Radical vulvectomy or
Radical local excision
Inguinal-femoral lymphadenectomy
Indicated for >1 mm dermal invasion
Postoperative groin and pelvic radiation
Indicated for >2 nodes positive
Prognosis
Five year survival
Stage I: 98%
Stage II: 85%
Stage III: 74%
Stage IV: 31%
Positive pelvic nodes: 11%
References
Muto in Ryan (1999) Kistner's Gynecology, p. 74-9
Canavan (2002) Am Fam Physician 66(7):1269-76 [PubMed]
Hopkins (2001) Obstet Gynecol Clin North Am 28(4):791 [PubMed]
Type your search phrase here